Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Valeri

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy TrialElizabeth C Smyth, Matteo Fassan, David Cunningham, et al.
Frontiers in Endocrinology|March 14, 2022
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA ProfilingFrancesca Galuppini, Simona Censi, Isabella Merante Boschin, et al.
Cancer Cell International|October 2, 2019
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastasesMatteo Fassan, Luca Vianello, Diana Sacchi, et al.
Oncotarget|September 13, 2014
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesisMatteo Fassan, Luigi Dall'Olmo, Marco Galasso, et al.
Cancer Cell International|September 12, 2018
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastasesMatteo Fassan, Luca Vianello, Diana Sacchi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Characterisation of the immune-related transcriptome in resected biliary tract cancersMichele Ghidini, Luciano Cascione, Pietro Carotenuto, et al.
Cell Death and Differentiation|July 6, 2021
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancerAndrea Lampis, Jens C Hahne, Pierluigi Gasparini, et al.
Trials|August 31, 2017
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trialNick J Battersby, Mit Dattani, Sheela Rao, et al.
Nature Communications|April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancerAhmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.
Oncotarget|January 18, 2018
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II studyGianluca Tomasello, Nicola Valeri, Michele Ghidini, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy TrialElizabeth C Smyth, Matteo Fassan, David Cunningham, et al.
Frontiers in Endocrinology|March 14, 2022
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA ProfilingFrancesca Galuppini, Simona Censi, Isabella Merante Boschin, et al.
Cancer Cell International|October 2, 2019
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastasesMatteo Fassan, Luca Vianello, Diana Sacchi, et al.
Oncotarget|September 13, 2014
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesisMatteo Fassan, Luigi Dall'Olmo, Marco Galasso, et al.
Cancer Cell International|September 12, 2018
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastasesMatteo Fassan, Luca Vianello, Diana Sacchi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Characterisation of the immune-related transcriptome in resected biliary tract cancersMichele Ghidini, Luciano Cascione, Pietro Carotenuto, et al.
Cell Death and Differentiation|July 6, 2021
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancerAndrea Lampis, Jens C Hahne, Pierluigi Gasparini, et al.
Trials|August 31, 2017
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trialNick J Battersby, Mit Dattani, Sheela Rao, et al.
Nature Communications|April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancerAhmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.
Oncotarget|January 18, 2018
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II studyGianluca Tomasello, Nicola Valeri, Michele Ghidini, et al.
Pageof 10